(Q86909112)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742772%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Liver resection versus radiofrequency ablation in the treatment of cirrhotic patients with hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742772%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742772%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Carlo Boselli

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742772%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Amilcare Parisi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742772%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Jacopo Desiderio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742772%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Stefano Trastulli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742772%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Elisa Castellani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742772%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Rosario Pasquale

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742772%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Giuseppe Noya

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742772%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

1 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742772%20AND%20SRC:MED&resulttype=core&format=json

Hepatobiliary & Pancreatic Diseases International

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742772%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742772%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742772%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

270-277

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742772%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of hepatocellular carcinoma

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Surveillance for hepatocellular carcinoma in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Updated management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Surgical management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Liver resection for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Percutaneous tumor ablation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics-a retrospective study of 1,061 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Partial hepatectomy versus radiofrequency ablation for hepatocellular carcinoma: confirming the trial that will never be, and some comments on the indications for liver resection

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Radiofrequency ablation versus surgical resection for single nodule hepatocellular carcinoma: long-term outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class a liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection?

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

The general rules for the clinical and pathological study of primary liver cancer. Liver Cancer Study Group of Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Sonographic characterisation of hepatocellular carcinoma at time of diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Radiofrequency Ablation of Malignant Liver Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Multidisciplinary management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Hepatocellular carcinoma: current management and future development-improved outcomes with surgical resection

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Radiofrequency ablation of liver tumors: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Laparoscopic radiofrequency ablation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Surgical and oncologic outcomes following laparoscopic versus open liver resection for hepatocellular carcinoma: A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Prognostic impact of anatomic resection for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

Comparison of limited and anatomic hepatic resection for hepatocellular carcinoma with hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960044-2

7 January 2021

10.1016/S1499-3872(13)60044-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23742772%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference